Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Sales | 10,701,000 | 8,853,000 | 7,328,000 | 7,726,000 | 8,314,000 |
Cost of Goods | 4,493,000 | 3,966,000 | 3,263,000 | 3,281,000 | 3,434,000 |
Gross Profit | 6,208,000 | 4,887,000 | 4,065,000 | 4,445,000 | 4,880,000 |
Operating Expenses | 3,776,000 | 3,392,000 | 3,393,000 | 3,687,000 | 3,491,000 |
Operating Income | 2,432,000 | 1,495,000 | 672,000 | 758,000 | 1,389,000 |
Interest Expense | 136,000 | 137,000 | 134,000 | 139,000 | 164,000 |
Other Income | 92,000 | 63,000 | -12,000 | 14,000 | 15,000 |
Pre-tax Income | 2,388,000 | 1,421,000 | 526,000 | 633,000 | 1,240,000 |
Income Tax | 230,000 | 189,000 | -11,000 | 89,000 | 191,000 |
Net Income Continuous | 2,158,000 | 1,232,000 | 537,000 | 544,000 | 1,049,000 |
Net Income Discontinuous | 4,000 | N/A | N/A | 20,000 | N/A |
Net Income | $2,162,000 | $1,232,000 | $537,000 | $564,000 | $1,049,000 |
EPS Basic Total Ops | 1.21 | 0.69 | 0.30 | 0.32 | 0.58 |
EPS Basic Continuous Ops | 1.21 | 0.69 | 0.30 | 0.31 | 0.58 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.01 | N/A |
EPS Diluted Total Ops | 1.20 | 0.69 | 0.30 | 0.31 | 0.59 |
EPS Diluted Continuous Ops | 1.20 | 0.69 | 0.30 | 0.30 | 0.59 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.01 | N/A |
EBITDA(a) | $3,298,000 | $2,303,000 | $1,497,000 | $1,586,000 | $2,145,000 |